Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 143

Similar articles for PubMed (Select 18061193)

1.

Influence of race and sex on lipoprotein-associated phospholipase A2 levels: observations from the Dallas Heart Study.

Brilakis ES, Khera A, McGuire DK, See R, Banerjee S, Murphy SA, de Lemos JA.

Atherosclerosis. 2008 Jul;199(1):110-5. Epub 2007 Dec 3.

2.

Association of lipoprotein-associated phospholipase A2 with coronary calcification among American and Japanese men.

El-Saed A, Sekikawa A, Zaky RW, Kadowaki T, Takamiya T, Okamura T, Edmundowicz D, Kita Y, Kuller LH, Ueshima H.

J Epidemiol. 2007 Nov;17(6):179-85.

3.

Racial variation in lipoprotein-associated phospholipase A₂ in older adults.

Lee KK, Fortmann SP, Varady A, Fair JM, Go AS, Quertermous T, Hlatky MA, Iribarren C.

BMC Cardiovasc Disord. 2011 Jun 29;11:38. doi: 10.1186/1471-2261-11-38.

4.

Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relationship with low-density lipoprotein cholesterol.

Jabor B, Choi H, Ruel I, Hafiane A, Mourad W, Genest J.

Can J Cardiol. 2013 Dec;29(12):1679-86. doi: 10.1016/j.cjca.2013.09.026. Epub 2013 Oct 2.

PMID:
24267807
5.

Lipoprotein-associated phospholipase A2, a novel cardiovascular inflammatory marker, in HIV-infected patients.

Mangili A, Ahmad R, Wolfert RL, Kuvin J, Polak JF, Karas RH, Wanke CA.

Clin Infect Dis. 2014 Mar;58(6):893-900. doi: 10.1093/cid/cit815. Epub 2013 Dec 11.

6.

Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.

Ballantyne CM, Hoogeveen RC, Bang H, Coresh J, Folsom AR, Chambless LE, Myerson M, Wu KK, Sharrett AR, Boerwinkle E.

Arch Intern Med. 2005 Nov 28;165(21):2479-84.

PMID:
16314544
7.
8.

Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.

Charniot JC, Khani-Bittar R, Albertini JP, Giral P, Cherfils C, Cosson C, Guillerm E, Leprince P, Gandjbakhch I, Bonnefont-Rousselot D.

Int J Cardiol. 2013 Sep 20;168(1):132-8. doi: 10.1016/j.ijcard.2012.09.054. Epub 2012 Oct 24.

PMID:
23103135
9.

[Lipoprotein-associated phospholipase A2 serum levels in patients from different categories of cardiovascular risk].

Nozadze DN, Sergienko IV, Balakhonova TV, Semenova AE, Vlasik TN, Kukharchuk VV.

Kardiologiia. 2014;54(3):57-63. Russian.

PMID:
25102750
10.

[Association of lipoprotein-associated phospholipase activity A2 with cardiovascular risk factors].

Acevedo M, Varleta P, Kramer V, Quiroga T, Prieto C, Parada J, Adasme M, Briones L, Navarrete C.

Rev Med Chil. 2013 Nov;141(11):1382-8. doi: 10.4067/S0034-98872013001100003. Spanish.

11.

Association of lipoprotein-associated phospholipase A2 mass and activity with calcified coronary plaque in young adults: the CARDIA study.

Iribarren C, Gross MD, Darbinian JA, Jacobs DR Jr, Sidney S, Loria CM.

Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):216-21. Epub 2004 Oct 21.

12.

Lp-PLA2 activity and PLA2G7 A379V genotype in patients with diabetes mellitus.

Wootton PT, Stephens JW, Hurel SJ, Durand H, Cooper J, Ninio E, Humphries SE, Talmud PJ.

Atherosclerosis. 2006 Nov;189(1):149-56. Epub 2006 Jan 24.

PMID:
16438975
13.

Taiwanese female vegetarians have lower lipoprotein-associated phospholipase A2 compared with omnivores.

Chen CW, Lin CT, Lin YL, Lin TK, Lin CL.

Yonsei Med J. 2011 Jan;52(1):13-9. doi: 10.3349/ymj.2011.52.1.13.

14.

High-sensitivity C-reactive protein and lipoprotein-associated phospholipase A2 stability before and after stroke and myocardial infarction.

Elkind MS, Leon V, Moon YP, Paik MC, Sacco RL.

Stroke. 2009 Oct;40(10):3233-7. doi: 10.1161/STROKEAHA.109.552802. Epub 2009 Jul 30.

15.

Lipoprotein-associated phospholipase A2 activity and risk of heart failure: The Rotterdam study.

van Vark LC, Kardys I, Bleumink GS, Knetsch AM, Deckers JW, Hofman A, Stricker BH, Witteman JC.

Eur Heart J. 2006 Oct;27(19):2346-52. Epub 2006 Sep 4.

16.

Relationship of oxidized phospholipids on apolipoprotein B-100 particles to race/ethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors: results from the Dallas Heart Study.

Tsimikas S, Clopton P, Brilakis ES, Marcovina SM, Khera A, Miller ER, de Lemos JA, Witztum JL.

Circulation. 2009 Apr 7;119(13):1711-9. doi: 10.1161/CIRCULATIONAHA.108.836940. Epub 2009 Mar 23.

17.

Eight genetic loci associated with variation in lipoprotein-associated phospholipase A2 mass and activity and coronary heart disease: meta-analysis of genome-wide association studies from five community-based studies.

Grallert H, Dupuis J, Bis JC, Dehghan A, Barbalic M, Baumert J, Lu C, Smith NL, Uitterlinden AG, Roberts R, Khuseyinova N, Schnabel RB, Rice KM, Rivadeneira F, Hoogeveen RC, Fontes JD, Meisinger C, Keaney JF Jr, Lemaitre R, Aulchenko YS, Vasan RS, Ellis S, Hazen SL, van Duijn CM, Nelson JJ, März W, Schunkert H, McPherson RM, Stirnadel-Farrant HA, Psaty BM, Gieger C, Siscovick D, Hofman A, Illig T, Cushman M, Yamamoto JF, Rotter JI, Larson MG, Stewart AF, Boerwinkle E, Witteman JC, Tracy RP, Koenig W, Benjamin EJ, Ballantyne CM.

Eur Heart J. 2012 Jan;33(2):238-51. doi: 10.1093/eurheartj/ehr372. Epub 2011 Oct 14.

18.

Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.

Kiechl S, Willeit J, Mayr M, Viehweider B, Oberhollenzer M, Kronenberg F, Wiedermann CJ, Oberthaler S, Xu Q, Witztum JL, Tsimikas S.

Arterioscler Thromb Vasc Biol. 2007 Aug;27(8):1788-95. Epub 2007 May 31.

19.

Lipoprotein-associated phospholipase A2 is an independent predictor of incident coronary heart disease in an apparently healthy older population: the Rancho Bernardo Study.

Daniels LB, Laughlin GA, Sarno MJ, Bettencourt R, Wolfert RL, Barrett-Connor E.

J Am Coll Cardiol. 2008 Mar 4;51(9):913-9. doi: 10.1016/j.jacc.2007.10.048.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk